Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure | Zendy

Milton Packer | Zendy; John J.V. McMurray | Zendy; Akshay S. Desai | Zendy; Jianjian Gong | Zendy; Martin Lefkowitz | Zendy; Adel R. Rizkala | Zendy; Jean L. Rouleau | Zendy; Victor Shi | Zendy; Scott D. Solomon | Zendy; Karl Swedberg | Zendy; Michael R. Zile | Zendy; Karl Andersen | Zendy; Juan Luis Arango | Zendy; J. Malcolm O. Arnold | Zendy; Jan Bělohlávek | Zendy; Michael Böhm | Zendy; S. А. Boytsov | Zendy; Lesley Burgess | Zendy; Walter Cabrera | Zendy; Carlos Calvo | Zendy; ChenHuan Chen | Zendy; Andrej Dukát | Zendy; Yan Duarte | Zendy; Andrejs Ērglis | Zendy; Michael Fu | Zendy; Efraín Gómez | Zendy; Angel Gonzàlez-Medina | Zendy; Albert Hagège | Zendy; Jun Huang | Zendy; Tzvetana Katova | Zendy; Songsak Kiatchoosakun | Zendy; KeeSik Kim | Zendy; Ömer Kozan | Zendy; Edmundo Bayram Llamas | Zendy; Felipe Martínez | Zendy; Béla Merkely | Zendy; Iván Mendoza | Zendy; Arend Mosterd | Zendy; Marta NegruszKawecka | Zendy; Keijo Peuhkurinen | Zendy; Félix José Alvarez Ramires | Zendy; Jens Refsgaard | Zendy; Arvo Rosenthal | Zendy; Michele Senni | Zendy; Antonio S. Sibulo | Zendy; José SilvaCardoso | Zendy; Iain Squire | Zendy; Randall C. Starling | Zendy; John R. Teerlink | Zendy; Johan Vanhaecke | Zendy; Dragoş Vinereanu | Zendy; Raymond Wong | Zendy

Open Access

Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

Author(s) -

Milton Packer,

John J.V. McMurray,

Akshay S. Desai,

Jianjian Gong,

Martin Lefkowitz,

Adel R. Rizkala,

Jean L. Rouleau,

Victor Shi,

Scott D. Solomon,

Karl Swedberg,

Michael R. Zile,

Karl Andersen,

Juan Luis Arango,

J. Malcolm O. Arnold,

Jan Bělohlávek,

Michael Böhm,

S. А. Boytsov,

Lesley Burgess,

Walter Cabrera,

Carlos Calvo,

ChenHuan Chen,

Andrej Dukát,

Yan Duarte,

Andrejs Ērglis,

Michael Fu,

Efraín Gómez,

Angel Gonzàlez-Medina,

Albert Hagège,

Jun Huang,

Tzvetana Katova,

Songsak Kiatchoosakun,

KeeSik Kim,

Ömer Kozan,

Edmundo Bayram Llamas,

Felipe Martínez,

Béla Merkely,

Iván Mendoza,

Arend Mosterd,

Marta NegruszKawecka,

Keijo Peuhkurinen,

Félix José Alvarez Ramires,

Jens Refsgaard,

Arvo Rosenthal,

Michele Senni,

Antonio S. Sibulo,

José SilvaCardoso,

Iain Squire,

Randall C. Starling,

John R. Teerlink,

Johan Vanhaecke,

Dragoş Vinereanu,

Raymond Wong

Publication year - 2014

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.114.013748

Subject(s) - medicine , enalapril , heart failure , hazard ratio , ejection fraction , cardiology , ace inhibitor , confidence interval , angiotensin converting enzyme , blood pressure

Clinical trials in heart failure have focused on the improvement in symptoms or decreases in the risk of death and other cardiovascular events. Little is known about the effect of drugs on the risk of clinical deterioration in surviving patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research